Patents-Review.com
ClassID:

97029 ⎘

C07K14/70503 - page 3 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants Immunoglobulin superfamily

Recent Application in this class:
#601
20200102567
2020-04-02

Chimeric antigen receptors targeting B-cell maturation antigen

 #602
20200095604
2020-03-26

Genomic engineering of pluripotent cells

 #603
20200095284
2020-03-26

MODULATION OF THE IMMUNE RESPONSE

 #604
20200087670
2020-03-19

Chimeric antigen receptors targeting B-cell maturation antigen

 #605
20200087669
2020-03-19

Chimeric antigen receptors targeting B-cell maturation antigen

 #606
20200087668
2020-03-19

Chimeric antigen receptors targeting B-cell maturation antigen

 #607
20200087667
2020-03-19

Chimeric antigen receptors targeting B-cell maturation antigen

 #608
20200086004
2020-03-19

METHODS OF MAKING CELLULAR COMPOSITIONS DERIVED FROM DECEASED DONORS TO PROMOTE GRAFT TOLERANCE

 #609
20200085962
2020-03-19

Dendrimer conjugates for coating cells

 #610
20200085930
2020-03-19

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

 #611
20200079869
2020-03-12

Anti-CD47 monoclonal antibody and use thereof

 #612
20200079864
2020-03-12

BCMA chimeric antigen receptors

 #613
20200071710
2020-03-05

Chimeric antigen receptors targeting b-cell maturation antigen

 #614
20200071709
2020-03-05

Chimeric antigen receptors targeting B-cell maturation antigen

 #615
20200071708
2020-03-05

Chimeric antigen receptors targeting B-cell maturation antigen

 #616
20200071707
2020-03-05

Chimeric antigen receptors targeting B-cell maturation antigen

 #617
20200071706
2020-03-05

Chimeric antigen receptors targeting B-cell maturation antigen

 #618
20200071705
2020-03-05

Chimeric antigen receptors targeting B-cell maturation antigen

 #619
20200071401
2020-03-05

Multipartite signaling proteins and uses thereof

 #620
20200071399
2020-03-05

MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF

 #621
20200071385
2020-03-05

Immunoglobulin chimeric monomer-dimer hybrids

 #622
20200069772
2020-03-05

METHODS OF TREATING EARLY RHEUMATOID ARTHRITIS

 #623
20200061171
2020-02-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

 #624
20200055917
2020-02-20

CHIMERIC ENGULFMENT RECEPTOR MOLECULES

 #625
20200055916
2020-02-20

Soluble CD33 for treating myelodysplastic syndromes (MDS)

 #626
20200054747
2020-02-20

MRNA combination therapy for the treatment of cancer

 #627
20200048364
2020-02-13

Recombinant bifunctional protein targeting CD47 and HER2

 #628
20200040059
2020-02-06

SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY

 #629
20200040053
2020-02-06

Ligands Modified by Circular Permutation as Agonists and Antagonists

 #630
20200038508
2020-02-06

Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

 #631
20200031927
2020-01-30

Anti-KIR3DL1 antibodies

 #632
20200030381
2020-01-30

Compositions and methods for inhibition of lineage specific proteins

 #633
20200024353
2020-01-23

PROTEINS BINDING PSMA, NKG2D AND CD16

 #634
20200023009
2020-01-23

Compositions and methods for CAR T cell therapy

 #635
20200022343
2020-01-23

Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof

 #636
20200017590
2020-01-16

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

 #637
20200016243
2020-01-16

TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68

 #638
20200016204
2020-01-16

CELL

 #639
20200016203
2020-01-16

Cell

 #640
20190389927
2019-12-26

CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA

 #641
20190382464
2019-12-19

Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo

 #642
20190375816
2019-12-12

High avidity antigen recognizing constructs

 #643
20190374662
2019-12-12

Modulation of immunity and CEACAM1 activity

 #644
20190367580
2019-12-05

CD200 mutants and its uses

 #645
20190365815
2019-12-05

Natural killer cell expressing anti-cotinine chimeric antigen receptor

 #646
20190365657
2019-12-05

TUMOR-TARGETING BEAD VECTORS AND METHODS OF USING THE SAME

 #647
20190364860
2019-12-05

Genetically modified non-human animal with human or chimeric LAG-3

 #648
20190359706
2019-11-28

LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS

 #649
20190359679
2019-11-28

Diagnostic, prognostic, therapeutic and screening protocols

 #650
20190359665
2019-11-28

Method for the affinity purification of recombinant proteins based on the lectin activity of the CRD of a galectin

 #651
20190352371
2019-11-21

PD1-41BBL fusion protein and methods of use thereof

 #652
20190351075
2019-11-21

Genetically modified mouse comprising a chimeric TIGIT

 #653
20190345219
2019-11-14

SWITCH COSTIMULATORY RECEPTORS

 #654
20190330304
2019-10-31

PD1-CD70 fusion protein and methods of use thereof

 #655
20190330303
2019-10-31

Methods for cancer therapy using isolated NTB-A ectodomain polypeptides

 #656
20190328907
2019-10-31

Genetically modified non-human animal with human or chimeric TIGIT

 #657
20190320632
2019-10-24

Non-human animals having a humanized lymphocyte-activation gene 3

 #658
20190316086
2019-10-17

Reducing immune tolerance induced by PD-L1

 #659
20190315879
2019-10-17

ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS

 #660
20190315862
2019-10-17

Methods and pharmaceutical compositions for the prophylactic treatment of metastases

 #661
20190315833
2019-10-17

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

 #662
20190315807
2019-10-17

Virus-like particles with high-density coating for inducing the expression of antibodies

 #663
20190314291
2019-10-17

COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS TO IMMUNE CELLS

 #664
20190309045
2019-10-10

Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy

 #665
20190309044
2019-10-10

POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS

 #666
20190307836
2019-10-10

Heterotandem bicyclic peptide complexes

 #667
20190276556
2019-09-12

Integral membrane protein display on poxvirus extracellular enveloped virions

 #668
20190276514
2019-09-12

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen

 #669
20190271005
2019-09-05

Genomic engineering of pluripotent cells

 #670
20190263886
2019-08-29

TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies

 #671
20190256574
2019-08-22

Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

 #672
20190248867
2019-08-15

MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC PEPTIDE FOR THE TREATMENT OR PREVENTION OF MULTIPLE SCLEROSIS

 #673
20190248866
2019-08-15

POLYPEPTIDES AND USES THEREOF FOR TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTION

 #674
20190233498
2019-08-01

Anti-PACAP antibodies and uses thereof

 #675
20190225661
2019-07-25

Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia

 #676
20190216851
2019-07-18

Modified cell expansion and uses thereof

 #677
20190194616
2019-06-27

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

 #678
20190192627
2019-06-27

Microvascular blood flow decreasing agent and use thereof

 #679
20190185860
2019-06-20

Manipulated immunoregulatory element and immunity altered thereby

 #680
20190177734
2019-06-13

Method of producing a recombinant protein

 #681
20190177396
2019-06-13

USE OF CD31 PEPTIDES IN THE TREATMENT OF THROMBOTIC AND AUTOIMMUNE DISORDERS

 #682
20190175726
2019-06-13

Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response

 #683
20190174730
2019-06-13

Transgenic mice expressing human TREM proteins and methods of use thereof

 #684
20190169266
2019-06-06

Constructs having a SIRP-alpha domain or variant thereof

 #685
20190169259
2019-06-06

BTNL3 proteins, nucleic acids and antibodies and uses thereof

 #686
20190153064
2019-05-23

COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS

 #687
20190135940
2019-05-09

Treatment of cancer using humanized anti-CD19 chimeric antigen receptor

 #688
20190135894
2019-05-09

COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF

 #689
20190133173
2019-05-09

Method using slit-robo system to treat sarcopenia

 #690
20190127439
2019-05-02

Engineered PD-1 variants

 #691
20190125833
2019-05-02

NOPE for treatment of pathological muscle loss and weakness

 #692
20190124895
2019-05-02

Non-human animals having a humanized signal-regulatory protein gene

 #693
20190119399
2019-04-25

Chimeric antigen receptors

 #694
20190117792
2019-04-25

Preparation of therapeutic exosomes using membrane proteins

 #695
20190117725
2019-04-25

Inhibition of TREM receptor signaling with peptide variants

 #696
20190112388
2019-04-18

Integral membrane protein display on poxvirus extracellular enveloped virions

 #697
20190112386
2019-04-18

Compositions and methods for tumor transduction

 #698
20190112372
2019-04-18

Multipartite signaling proteins and uses thereof

 #699
20190106478
2019-04-11

Fusion proteins of PD-1 and 4-1BB

 #700
20190060483
2019-02-28

Preparation of therapeutic exosomes using membrane proteins

 #701
20190060430
2019-02-28

Antigen-specific T cell receptors and T cell epitopes

 #702
20190060398
2019-02-28

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

 #703
20190060364
2019-02-28

Intracellular genomic transplant and methods of therapy

 #704
20190060363
2019-02-28

Intracellular genomic transplant and methods of therapy

 #705
20190054130
2019-02-21

Treatment methods using adenovirus

 #706
20190054122
2019-02-21

Intracellular genomic transplant and methods of therapy

 #707
20190048082
2019-02-14

Oncolytic viral delivery of therapeutic polypeptides

 #708
20190046570
2019-02-14

Compositions and Methods for Recombinant CXADR Expression

 #709
20190040415
2019-02-07

Cultured transgenic cell allowing growth of norovirus, and use thereof

 #710
20190038672
2019-02-07

Cell

 #711
20190031733
2019-01-31

Affinity maturated T cell receptors and use thereof

 #712
20190024145
2019-01-24

Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens

 #713
20190017021
2019-01-17

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

 #714
20190016777
2019-01-17

T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

 #715
20190016776
2019-01-17

Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironment

 #716
20190015493
2019-01-17

ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN

 #717
20190010514
2019-01-10

Method for generating T-cells compatible for allogenic transplantation

 #718
20190010220
2019-01-10

Conditionally active chimeric antigen receptors for modified t-cells

 #719
20190010207
2019-01-10

PD-1-CD28 fusion proteins and their use in medicine

 #720
20190008937
2019-01-10

Peptides and combination of peptides for use in immunotherapy against cancers

 #721
20190008899
2019-01-10

Tumor infiltrating lymphocytes and methods of therapy

 #722
20190002578
2019-01-03

Targeted protein degradation

 #723
20180371435
2018-12-27

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

 #724
20180369374
2018-12-27

MRNA combination therapy for the treatment of cancer

 #725
20180369326
2018-12-27

Peptides and methods related to ICOS signaling

 #726
20180369282
2018-12-27

GENE-MODIFIED LYMPHOCYTES EXPRESSING CHIMERIC ANTIGEN RECEPTOR IN WHICH PRODUCTION OF INFLAMMATORY CYTOKINES IS INHIBITED

 #727
20180362940
2018-12-20

Expression of novel cell tags

 #728
20180362651
2018-12-20

Methods and antibodies for modulation of immunoresponse

 #729
20180355053
2018-12-13

SIRP alpha-antibody fusion proteins

 #730
20180355039
2018-12-13

Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors

 #731
20180348227
2018-12-06

Cancer antigen targets and uses thereof

 #732
20180346566
2018-12-06

METHODS AND COMPOSITIONS RELATING TO ANTI-TMIGD1/IGPR-2

 #733
20180346542
2018-12-06

Recombinant ROBO2 proteins, compositions, methods and uses thereof

 #734
20180340021
2018-11-29

Conditionally active chimeric antigen receptors for modified T-cells

 #735
20180340017
2018-11-29

CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA

 #736
20180339987
2018-11-29

Compound I and compound II as well as preparation methods therefor and application thereof

 #737
20180334668
2018-11-22

Triple-mode system for antibody maturation, surface display and secretion

 #738
20180326032
2018-11-15

Chimeric antigen receptors targeting HER2

 #739
20180326028
2018-11-15

CD200 inhibitors and methods of use thereof

 #740
20180312806
2018-11-01

Inhibition of innate immune response

 #741
20180312564
2018-11-01

Antibodies against novel PD1 isoforms and uses thereof

 #742
20180312563
2018-11-01

Treatment of CD47+ disease cells with SIRPα-Fc fusions

 #743
20180311269
2018-11-01

Targeted cancer therapy

 #744
20180305451
2018-10-25

HIDE1 COMPOSITIONS AND METHODS

 #745
20180305434
2018-10-25

Engineering t cell receptors

 #746
20180303922
2018-10-25

Regulatory T cell PD-1 modulation for regulating T cell effector immune responses

 #747
20180298109
2018-10-18

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

 #748
20180298095
2018-10-18

INTERACTIONS BETWEEN CEACAM AND TIM FAMILY MEMBERS

 #749
20180291343
2018-10-11

Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients

 #750
20180282416
2018-10-04

Methods to protect transplanted tissue from rejection

 #751
20180282412
2018-10-04

PD-1 antibodies and uses thereof

 #752
20180273601
2018-09-27

Immune cell compositions and methods of use

 #753
20180265894
2018-09-20

Gene Expression Cassette And Product Thereof

 #754
20180265846
2018-09-20

Chimeric antigen receptor anti-inflammatory cells and methods of use

 #755
20180265595
2018-09-20

ANTI-CD19 scFv (FMC63) POLYPEPTIDE AND USES THEREOF

 #756
20180258149
2018-09-13

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

 #757
20180252719
2018-09-06

SYSTEM FOR IMMUNOTHERAPY TARGETING TUMOR PROPAGATION AND PROGRESSION

 #758
20180251550
2018-09-06

Methods of increasing T cell immune response in the treatment of cancer

 #759
20180251520
2018-09-06

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

 #760
20180251519
2018-09-06

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

 #761
20180249689
2018-09-06

Method of using mouse having a humanized cluster of differentiation 47 gene

 #762
20180237483
2018-08-23

Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia

 #763
20180230230
2018-08-16

Anti-glypican-1-immunizing antigen receptor

 #764
20180214527
2018-08-02

BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS

 #765
20180208638
2018-07-26

T CELL RECEPTORS

 #766
20180200352
2018-07-19

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

 #767
20180200350
2018-07-19

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

 #768
20180194829
2018-07-12

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER

 #769
20180186897
2018-07-05

NOVEL VACCINES IN PREVENTION AND TREATMENT OF MALARIA

 #770
20180185525
2018-07-05

CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS

 #771
20180179289
2018-06-28

Use of chimeric antigen receptor modified cells to treat cancer

 #772
20180179274
2018-06-28

PROTEINS COMPRISING A MUTATED LAIR-1 FRAGMENT AND USES THEREOF

 #773
20180177902
2018-06-28

CEACAM1 MEDIATED PROTECTIVE IMMUNITY

 #774
20180162942
2018-06-14

Treatment of renal cell carcinoma

 #775
20180160662
2018-06-14

Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha

 #776
20180155717
2018-06-07

Genomic engineering of pluripotent cells

 #777
20180155405
2018-06-07

SIRP-gamma polypeptide compositions and methods of use

 #778
20180148508
2018-05-31

Masking chimeric antigen receptor T cells for tumor-specific activation

 #779
20180148493
2018-05-31

HIV VPR-specific T-cell receptors

 #780
20180147240
2018-05-31

NKP30 receptor targeted therapeutics

 #781
20180142207
2018-05-24

Induction of arterial-type of hemogenic endothelium (AHE) and enhancement of T cell production from PSCs through overexpression of ETS factors or modulating MAPK/ERK signalling pathways

 #782
20180142035
2018-05-24

Compositions and methods for treatment of cancer

 #783
20180141991
2018-05-24

METHODS AND POLYPEPTIDES FOR MODULATION OF IMMUNORESPONSE

 #784
20180141975
2018-05-24

Compositions and methods for inhibiting CD279 interactions

 #785
20180140635
2018-05-24

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

 #786
20180139941
2018-05-24

Non-human animals having a humanized signal-regulatory protein gene

 #787
20180133254
2018-05-17

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

 #788
20180127502
2018-05-10

PD-1 immune modulating agents

 #789
20180127480
2018-05-10

High affinity CD47 analogs

 #790
20180125934
2018-05-10

Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway

 #791
20180120299
2018-05-03

Tim protein-bound carrier, methods for obtaining, removing and detecting extracellular membrane vesicles and viruses using said carrier, and kit including said carrier

 #792
20180111994
2018-04-26

LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS

 #793
20180111993
2018-04-26

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

 #794
20180105573
2018-04-19

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

 #795
20180104187
2018-04-19

Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer

 #796
20180100016
2018-04-12

USE OF CAR-MODIFIED HUMAN NATURAL KILLER CELLS TO TREAT CANCER

 #797
20180086802
2018-03-29

Myelin oligodendrocyte glycoprotein (MOG) peptide

 #798
20180064758
2018-03-08

CHIMERIC ANTIGEN RECEPTOR

 #799
20180057594
2018-03-01

PSEUDOTYPED ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES

 #800
20180051292
2018-02-22

Chimeric antigen receptors targeting B-cell maturation antigen

 #801
20180050111
2018-02-22

Dendrimer conjugates for coating cells

 #802
20180044404
2018-02-15

IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF

 #803
20180044399
2018-02-15

Inhibitory chimeric antigen receptors

 #804
20180030142
2018-02-01

SIRP alpha-antibody fusion proteins

 #805
20180022821
2018-01-25

Compositions and methods for tumor transduction

 #806
20180022795
2018-01-25

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

 #807
20180016335
2018-01-18

Chimeric antigen receptor signalling system comprising heterodimerization domains

 #808
20180016320
2018-01-18

Methods and compositions for modulating toso activity

 #809
20180015182
2018-01-18

Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins

 #810
20180002398
2018-01-04

Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy

 #811
20180002397
2018-01-04

CD33 specific chimeric antigen receptors

 #812
20170362295
2017-12-21

Use of ICOS-based CARS to enhance antitumor activity and CAR persistence

 #813
20170354681
2017-12-14

T CELL-BASED IMMUNOTHERAPEUTICS

 #814
20170354129
2017-12-14

Biotinylated and oxidized LDL receptor and advanced glycation end product receptor produced using genetically engineered silkworm

 #815
20170342164
2017-11-30

ANTI-CD19 scFv (FMC63) POLYPEPTIDE

 #816
20170342126
2017-11-30

HLA-DR binding peptides and their uses

 #817
20170335404
2017-11-23

Inhibitors of cell adhesion

 #818
20170335311
2017-11-23

CHIMERIC PROTEIN

 #819
20170335010
2017-11-23

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

 #820
20170334990
2017-11-23

VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof

 #821
20170333573
2017-11-23

Methods and compositions relating to improved lentiviral vectors and their applications

 #822
20170333481
2017-11-23

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

 #823
20170327591
2017-11-16

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

 #824
20170320946
2017-11-09

RECEPTOR TREM (TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS) AND USES THEREOF

 #825
20170313758
2017-11-02

Polypeptides for the Treatment of Angiogenesis or Lymphangiogenesis-Related Diseases

 #826
20170298127
2017-10-19

Anti-PACAP antibodies and uses thereof

 #827
20170298115
2017-10-19

Humanized anti-PACAP antibodies and uses thereof

 #828
20170296641
2017-10-19

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

 #829
20170290893
2017-10-12

Treatment of infection by human enterovirus D68

 #830
20170283481
2017-10-05

Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

 #831
20170274095
2017-09-28

ENHANCED REGULATORY T CELLS TARGETED TO SITES OF INFLAMMATION WITH CHIMERIC ANTIGEN RECEPTORS AND EXPRESSING FACTORS THAT ENHANCE VIABILITY OF PANCREATIC CELLS

 #832
20170274003
2017-09-28

BLOCKING PIRB UPREGULATES SPINES AND FUNCTIONAL SYNAPSES TO UNLOCK VISUAL CORTICAL PLASTICITY AND FACILITATE RECOVERY FROM AMBLYOPIA

 #833
20170267758
2017-09-21

IMMUNOTHERAPY WITH BINDING AGENTS

 #834
20170266309
2017-09-21

Immunoglobulin chimeric monomer-dimer hybrids

 #835
20170266271
2017-09-21

Peptides and combination of peptides for use in immunotherapy against cancers

 #836
20170265442
2017-09-21

Non-human animals having a humanized signal-regulatory protein gene

 #837
20170260288
2017-09-14

Compositions and methods for tumor transduction

 #838
20170260268
2017-09-14

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

 #839
20170254807
2017-09-07

Method for detecting and purifying pancreatic beta cells

 #840
20170254749
2017-09-07

Systems and methods for obtaining information associated with an anatomical sample using optical microscopy

 #841
20170248594
2017-08-31

Assay for detection of chimeric antigen receptor T cells

 #842
20170247428
2017-08-31

Chimeric antigen receptors

 #843
20170240613
2017-08-24

Compositions and methods for modulating T-cell mediated immune response

 #844
20170233451
2017-08-17

High affinity PD-1 agents and methods of use

 #845
20170233450
2017-08-17

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

 #846
20170226216
2017-08-10

BCMA CHIMERIC ANTIGEN RECEPTORS

 #847
20170226189
2017-08-10

Immunoglobulin chimeric monomer-dimer hybrids

 #848
20170226184
2017-08-10

Soluble hybrid Fcγ receptors and related methods

 #849
20170226162
2017-08-10

Enhanced production of immunoglobulins

 #850
20170219591
2017-08-03

PANCREATIC CANCER TARGETS AND USES THEREOF

 #851
20170218336
2017-08-03

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

 #852
20170218082
2017-08-03

Human soluble CD146, preparation and uses thereof

 #853
20170218043
2017-08-03

T cell receptors

 #854
20170209492
2017-07-27

SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS

 #855
20170174771
2017-06-22

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

 #856
20170174742
2017-06-22

TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies

 #857
20170166657
2017-06-15

Macrophage CAR (MOTO-CAR) in immunotherapy

 #858
20170166623
2017-06-15

Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule

 #859
20170165341
2017-06-15

Replication defective adenovirus vector in vaccination

 #860
20170159025
2017-06-08

Nucleic acids encoding chimeric antigen receptor proteins which bind epidermal growth factor receptor and T lymphocyte expressing the protein

 #861
20170157228
2017-06-08

Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses Thereof

 #862
20170145093
2017-05-25

Compositions and methods for the treatment of immune related diseases

 #863
20170142943
2017-05-25

Non-human animals having a humanized lymphocyte-activation gene 3

 #864
20170130200
2017-05-11

Intracellular genomic transplant and methods of therapy

 #865
20170129954
2017-05-11

Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus Arteritis

 #866
20170119876
2017-05-04

Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response

 #867
20170119820
2017-05-04

MODIFIED CELLS AND METHODS OF THERAPY

 #868
20170114412
2017-04-27

Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2

 #869
20170107270
2017-04-20

Constructs having a SIRP-α domain or variant thereof

 #870
20170097333
2017-04-06

CELL BASED ASSAY TO MEASURE THE T-CELL STIMULATING CAPACITY OF ANTI-LAG3 ANTIBODIES AND OTHER AGENTS

 #871
20170096638
2017-04-06

Reducing immune tolerance induced by PD-L1

 #872
20170087185
2017-03-30

Genetic engineering of macrophages for immunotherapy

 #873
20170081410
2017-03-23

COMPOSITIONS AND METHODS FOR TARGETING A PATHWAY

 #874
20170080104
2017-03-23

Cell surface coupling of nanoparticles

 #875
20170067910
2017-03-09

Detection of platelet-derived shed CD31

 #876
20170067079
2017-03-09

METHODS AND COMPOSITIONS RELATING TO RESTRICTED EXPRESSION LENTIVIRAL VECTORS AND THEIR APPLICATIONS

 #877
20170067021
2017-03-09

Modified cells and methods of therapy

 #878
20170065706
2017-03-09

HPV vaccines and methods of use thereof

 #879
20170065693
2017-03-09

Breast cancer vaccines and methods of use thereof

 #880
20170065636
2017-03-09

Modified cells and methods of therapy

 #881
20170056527
2017-03-02

Thymidylate kinase fusions and uses thereof

 #882
20170056473
2017-03-02

EBV antigen specific T-cell receptor and use thereof

 #883
20170051057
2017-02-23

Antibodies to MAdCAM

 #884
20170044228
2017-02-16

Ligands modified by circular permutation as agonists and antagonists

 #885
20170042972
2017-02-16

USE OF CTLA4 COMPOUND FOR ACHIEVING DRUG-FREE REMISSION IN SUBJECTS WITH EARLY RA

 #886
20170042939
2017-02-16

NKT-like cell subpopulation and method of using the same in the treatment of tumor

 #887
20170029485
2017-02-02

Human Tim-3 fusion protein capable of blocking Tim-3 signaling pathway

 #888
20170027140
2017-02-02

Human SIRPα transgenic mice and their methods of use

 #889
20170016025
2017-01-19

METHOD FOR GENERATING T-CELLS COMPATIBLE FOR ALLOGENIC TRANSPLANTATION

 #890
20170008951
2017-01-12

FUSION PROTEINS COMPRISING IGG2 HINGE DOMAINS

 #891
20170008947
2017-01-12

Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

 #892
20160376339
2016-12-29

Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1

 #893
20160375152
2016-12-29

Methods and compositions relating to improved lentiviral vectors and their applications

 #894
20160374321
2016-12-29

Non-human animals having a humanized signal-regulatory protein gene

 #895
20160368965
2016-12-22

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

 #896
20160355566
2016-12-08

Synthetic biology-based ADCC technology

 #897
20160347816
2016-12-01

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER

 #898
20160345549
2016-12-01

NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE

 #899
20160333072
2016-11-17

Cell compositions and methods for cancer therapy

 #900
20160326231
2016-11-10

Inhibitor targeting specific complement system, and preparation method and use thereof